Neurogenomics
To identify the genetic drivers of neurological, neuromuscular, and neurodegenerative disorders scientists must have access to the complete genomic landscape, including regions previously deemed impossible to sequence, and the tools to examine the full range of genomic variation.
Discover deeper insights
The PacBio systems using Single Molecule, Real-Time (SMRT) sequencing provide exceptionally long reads, uniform coverage and high consensus accuracy. This technology enables scientists to gain a more comprehensive understanding of the genetic basis of neurological disease.
Explore the range of applications
Targeting sequencing
Targeting sequencing of candidate genes with pre-designed capture panels or long-range PCR to enrich and sequence multi-kilobase fragments
Variant detection
Variant detection to phase alleles and screen for variants including SNPs, complex structural variants like repeat expansions, and long homopolymers
RNA sequencing
RNA sequencing of full-length isoforms of disease-relevant genes to characterize the complete landscape of gene-specific transcripts
Spotlight
Alzheimer’s study reveals first somatic gene recombination found in human neurons
Using an impressive array of novel and cutting-edge technologies, the scientists found evidence of significant recombination in the APP gene, which encodes amyloid precursor protein in neurons and has been associated with Alzheimer’s. Explore this research further.
Lee, M.-H. et al. 2018. Somatic APP gene recombination in Alzheimer’s disease and normal neurons. Nature 563(7733):639-645.
Spotlight
Sequencing ALS-causing repeat expansion using No-amp targeted sequencing method
Scientists used both whole genome long-read sequencing and amplification-free targeted sequencing using the CRISPR-Cas9 system to gain base-level resolution of the notoriously challenging C9orf72 repeat expansion causing amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Ebbert, M. T. W. et al. 2018. Long-read sequencing across the C9orf72 ‘GGGGCC’ repeat expansion: implications for clinical use and genetic discovery efforts in human disease. Molecular Neurodegeneration, 13(1):46.
Learn more about the No-amp targeted sequencing method.